Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/56299
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSallustio, B.en
dc.contributor.authorDavies, B.en
dc.contributor.authorColler, J.en
dc.contributor.authorJames, H.en
dc.contributor.authorGillis, D.en
dc.contributor.authorSomogyi, A.en
dc.date.issued2003en
dc.identifier.citationTherapeutic Drug Monitoring, 2003; 25(4):519en
dc.identifier.issn0163-4356en
dc.identifier.urihttp://hdl.handle.net/2440/56299-
dc.description.statementofresponsibilitySallustio, BC; Davies, BJL; Coller, JK; James, HM; Gillis, D. and Somogyi, AAen
dc.description.urihttp://apps.isiknowledge.com/summary.do?qid=1&product=WOS&SID=S138aPlEnpLJ4GkAo19&search_mode=GeneralSearchen
dc.language.isoenen
dc.publisherLippincott Williams & Wilkinsen
dc.titleRelationship between CYP2D6 genotype and plasma OH-perhexiline/perhexiline concentration ratio in angina patients.en
dc.typeJournal articleen
dc.identifier.rmid0020091886en
dc.identifier.pubid38044-
pubs.library.collectionPharmacology publicationsen
pubs.verification-statusVerifieden
pubs.publication-statusPublisheden
dc.identifier.orcidSallustio, B. [0000-0002-0186-3073]en
dc.identifier.orcidColler, J. [0000-0002-8273-5048]en
dc.identifier.orcidSomogyi, A. [0000-0003-4779-0380]en
Appears in Collections:Pharmacology publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.